Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:80915 |
Name | histiocytic sarcoma |
Definition | A histiocytic and dendritic cell cancer that is characterized by the presence of neoplastic cells with morphologic and immunophenotypic characteristics similar to those seen in mature histiocytes. |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer organ system cancer hematologic cancer histiocytic and dendritic cell cancer histiocytic sarcoma |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|---|---|---|---|
MAP2K1 F53L | Trametinib | histiocytic sarcoma | predicted - sensitive | detail... |
BRAF V600E | Trametinib | histiocytic sarcoma | predicted - sensitive | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05961761 | Phase II | Pembrolizumab + Propranolol | Propranolol and Pembrolizumab in Advanced Soft Tissue Sarcoma Patients (PROPANE) | Recruiting | SWE | NOR | DNK | 0 |